iollo

Startup

iollo is a Stanford spinout, co-founded with Prof. Michael Snyder and backed by Y Combinator. We developed Quinn, an AI scientist that transforms how pharma and biotech companies move from discovery to submission.

Quinn analyzes your data, like omics, clinical, screening, safety, and delivers regulatory-grade outputs: validated targets with mechanisms, IND-enabling packages, CSR sections, and CTD-ready modules. Every analysis includes validated methods, and complete documentation that satisfies FDA requirements.

For biotech companies and pharma teams, Quinn compresses years of work into weeks: target ID (from 6 months down to 2 days), IND prep (from 3 months down to 2 days), Phase 3 analysis (from 6 months down to 2 days). Unlike platforms that provide insights, Quinn delivers submission-ready deliverables that accelerate your pipeline while reducing risk, without the need for additional internal resources or headcount.

website